Covered recipient · General Payments record
JASMEEN K UPPAL
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2021–2024
$1,087.38
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $457.40 | 17 |
| Education | $19.25 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $276.77 | 9 |
| Aurinia Pharma U.S., Inc. | $55.84 | 3 |
| Janssen Biotech, Inc. | $41.65 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40.96 | 2 |
| ABBVIE INC. | $28.07 | 1 |
| SOBI, INC | $19.25 | 1 |
| Acerta Pharma LLC | $14.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.07 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106260588 | CMS |
| Amgen Inc. | $24.32 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730087 | CMS |
| Amgen Inc. | $30.68 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730089 | CMS |
| Amgen Inc. | $11.27 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730085 | CMS |
| Amgen Inc. | $18.46 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730093 | CMS |
| Amgen Inc. | $18.25 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730091 | CMS |
| Amgen Inc. | $25.00 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117403900 | CMS |
| Amgen Inc. | $125.00 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117403902 | CMS |
| Amgen Inc. | $10.36 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117706574 | CMS |
| Amgen Inc. | $13.43 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111730095 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.11 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105335648 | CMS |
| Aurinia Pharma U.S., Inc. | $17.09 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150693755 | CMS |
| Aurinia Pharma U.S., Inc. | $21.07 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150693757 | CMS |
| Aurinia Pharma U.S., Inc. | $17.68 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150693759 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.00 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118164702 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.96 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118164704 | CMS |
| Janssen Biotech, Inc. | $41.65 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078778468 | CMS |
| SOBI, INC | $19.25 | 08/16/2024 | Education | Undisputed | 01/23/2026 | 1141411158 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.